Nuveen Asset Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $836K | Hold |
67,877
| – | – | ﹤0.01% | 2786 |
|
|
2024
Q3 | $822K | Buy |
67,877
+1,248
| +2% | +$15.1K | ﹤0.01% | 2840 |
|
|
2024
Q2 | $780K | Buy |
66,629
+31,798
| +91% | +$372K | ﹤0.01% | 2839 |
|
|
2024
Q1 | $450K | Hold |
34,831
| – | – | ﹤0.01% | 3008 |
|
|
2023
Q4 | $300K | Buy |
34,831
+15,676
| +82% | +$135K | ﹤0.01% | 3147 |
|
|
2023
Q3 | $182K | Hold |
19,155
| – | – | ﹤0.01% | 3052 |
|
|
2023
Q2 | $327K | Buy |
19,155
+3,021
| +19% | +$51.5K | ﹤0.01% | 2991 |
|
|
2023
Q1 | $253K | Buy |
+16,134
| New | +$253K | ﹤0.01% | 2945 |
|